The observation of tumor shrinkage in both the injected tumor and surrounding non-injected lesion was most notable in a patient with durable SD supports the notion that local induction of OX40L, followed by expansion of tumor-specific T cells, may broaden the immune response beyond the direct field of injection. This evidence concerns the gene TNFSF4 and neoplasm.